FACTFLOW

Thursday, 23 April 2026 · Global Edition · Updated 07:25 CST

Niagen Bioscience targets 10–15% revenue growth for 2026 while expanding injectable product line

Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy

Smith Micro outlines leadership transition and targets Q2 2026 non-GAAP profitability amid strong SafePath OS momentum

Baytex Energy President/COO Lundberg to succeed Greager as CEO

Verastem outlines 2026 milestones with CO-PACK franchise set to be self-sustaining in H2

Baytex Energy GAAP EPS of -C$1.12, revenue of C$759.82M

ReGen III launches $4M private placement financing

Broadcom in charts: Revenue from semiconductor solutions rises 52% Y/Y

Versamet Royalties upsizes revolving credit facility to $225 million

Nexxen outlines over 8% contribution ex-TAC growth target for 2026 as enterprise and CTV drive momentum

EyePoint outlines mid-2026 topline data target for DURAVYU in wet AMD and DME as Phase III trials advance

Cracker Barrel FQ2 results better than feared, narrows FY26 sales outlook

Viemed Healthcare authorizes share repurchase program through March 2027

Big Tech trade group warns Anthropic ban could hinder tech access

BTIG’s Jonathan Krinsky: Investors should shift to an offensive positioning strategy

Prev 1 … 189 190 191 192 193 194 195 … 321 Next